Right to Safe Blood: Supreme Court seeks NAT test cost, availability in Govt Hospitals

New Delhi: The Supreme Court sought detailed information on the costs and availability of conducting Nucleic Acid Amplification Testing (NAT) in government hospitals across the country to detect Transfusion Transmissible Infections like HIV and hepatitis. 

A bench comprising Chief Justice Surya Kant and justices Joymalya Bagchi and Vipul M Pancholi asked lawyer A Velan, appearing for PIL petitioner ‘Sarvesham Mangalam Foundation’, to provide details as to how much cost will be incurred in conducting NAT tests and whether the facility was available in government hospitals so that poor can also avail it, news agency PTI reported.

The foundation made the Union Ministry of Health and Family Welfare and all the states and UTs (union territories) as parties to the plea.

Also Read:LNJP Hospital to launch Medical Genetics Ward, NAT Facility

The PIL sought an order to the Centre and the states to declare that the “Right to Safe Blood” is an intrinsic facet of the Right to Life under Article 21 of the Constitution.

It also sought directions to “implement mandatory NAT in all blood banks across the territory of India for the detection of Transfusion Transmissible Infections (TTIs), including Human Immunodeficiency Virus (HIV), hepatitis C Virus (HCV), hepatitis B Virus (HBV), malaria, and syphilis, in the blood collected from all donors, to ensure the supply of safe and infection-free blood to all recipients.” The Delhi-based NGO highlighted a “systemic and ongoing failure” of the state to protect vulnerable patients, particularly those with Thalassemia, from life-threatening TTIs such as HIV, hepatitis B, and hepatitis C. Thalassemia is a genetic blood disorder requiring patients to undergo blood transfusions every 15 to 20 days for survival, reports PTI.

However, the petition said that for thousands in India, these transfusions have become a “gamble with death.” “Thalassemia is an inherited blood disorder which is caused by the body’s inability to produce enough haemoglobin, the protein in red blood cells that transports oxygen from the lungs to the tissues and carbon dioxide to the lungs. As India is the Thalassemia capital of the world, there is a need to strengthen blood safety practices across the country…particularly the need for a standardised test to screen blood donations,” it said.

The PIL highlighted a string of recent “preventable tragedies” across the country and said in Madhya Pradesh, in 2025, at least six Thalassemic children tested HIV-positive following blood transfusions at Satna District Hospital.

In Jharkhand, five children were infected with HIV following transfusions at Sadar Hospital, Chaibasa, in 2025, it said, adding that in Uttar Pradesh, 14 children contracted hepatitis and HIV at a medical college in 2023.

Also Read:Lok Nayak Hospital Opens Delhi's First Model Treatment Centre for Hepatitis